These numbers are not sustainable for our government, and they are certainly not sustainable for the families.

I am convening this hearing today to assess our progress in combating Alzheimer's disease since the enactment of the National Alzheimer's Project Act which I co-authored with my friend and former colleague, Senator Evan Bayh.

If we do not likewise see that type of increase to our shipbuilding budget, then we will not be able to execute the long-range plan.

Yet when we are going to need it, we are going to really need it, and if it is not there, we are going to suffer the consequences.

We are not fully meeting our fundamental responsibility in the preamble of the Constitution to provide for the common defense.

We had a hearing the other day on the Navy. We've got a bulge of acquisition coming.

The idea is that the AAV will be used to get the marines ashore.

It seems to me that we and the Congress have to really be talking about this.

I just heard on the way over that the Navy has made a decision to name the DDG-120 the Senator Carl Levin, which I compliment.

I just think we need some fundamental rethinking of what we are trying to do here and the threats we are trying to meet.

The reality is defense spending as a percentage of GDP is the lowest today that it has been in 70 years.

Of course a multiyear is always going to be better for the taxpayer than one at a time.

Our proud State of Maine has sent many hardworking, principled leaders to the national stage. Senator Margaret Chase Smith brought common sense and courage to Washington as the first woman to serve in both the U.S. House and in the Senate…

I support adequately funding all the OIGs contained in your bill.

I strongly urge the BLM to abandon these proposed experiments in favor of using proven, more cost-effective and humane fertility control methods.

I request that you provide at least $2 million for the Community Forest and Open Space Conservation Program.

SUDDEN PRICE SPIKES IN DECADES-OLD PRESCRIPTION DRUGS: INSIDE THE MONOPOLY BUSINESS MODEL

Well, there is absolutely no reason, according to the medical experts that we have talked to, to put this drug into a specialty pharmacy or a restricted distribution system other than to prevent generics from buying up enough of the drug…